These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 10346672)

  • 1. Overview of FDA regulation of human cellular and tissue-based products.
    Wells MA
    Food Drug Law J; 1997; 52(4):401-8. PubMed ID: 10346672
    [No Abstract]   [Full Text] [Related]  

  • 2. The commodification of human body parts: regulating the tissue bank industry.
    Zodrow JJ
    Southwest Univ Law Rev; 2003; 32(3):407-49. PubMed ID: 15212024
    [No Abstract]   [Full Text] [Related]  

  • 3. Human cells, tissues, and cellular and tissue-based products; establishment registration and listing. Food and Drug Administration, HHS. Final rule.
    Fed Regist; 2001 Jan; 66(13):5447-69. PubMed ID: 11503777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The regulation of human tissue in the United States: a regulatory and legislative analysis.
    Williams MO
    Food Drug Law J; 1997; 52(4):409-28. PubMed ID: 10346673
    [No Abstract]   [Full Text] [Related]  

  • 5. Current good tissue practice for human cell, tissue, and cellular and tissue-based product establishments; inspection and enforcement. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2004 Nov; 69(226):68611-88. PubMed ID: 15562555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human cells, tissues, and cellular and tissue-based products; establishment registration and listing. Interim final rule; opportunity for public comment.
    Food and Drug Administration, HHS
    Fed Regist; 2004 Jan; 69(17):3823-6. PubMed ID: 14968801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Informed consent and living human cells.
    Maloney DM
    Hum Res Rep; 2002 Jul; 17(7):3. PubMed ID: 12731490
    [No Abstract]   [Full Text] [Related]  

  • 8. Skin and bones: post-mortem markets in human tissue.
    Charo RA
    Nova Law Rev; 2002; 26(2):421-50. PubMed ID: 12627562
    [No Abstract]   [Full Text] [Related]  

  • 9. [The tissue law--new legal directives].
    Gaissmaier C; Fritz J; Niethard FU; Weise K; Bauer H; Pannenbecker A
    Z Orthop Unfall; 2007; 145(5):541-5. PubMed ID: 17955419
    [No Abstract]   [Full Text] [Related]  

  • 10. Human tissue intended for transplantation--FDA. Interim rule; opportunity for public comment.
    Fed Regist; 1993 Dec; 58(238):65514-21. PubMed ID: 10131341
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bringing safe and effective cell therapies to the bedside.
    Preti RA
    Nat Biotechnol; 2005 Jul; 23(7):801-4. PubMed ID: 16003360
    [No Abstract]   [Full Text] [Related]  

  • 12. Establishment registration and listing for manufacturers of human cellular and tissue-based products--FDA. Proposed rule.
    Fed Regist; 1998 May; 63(93):26744-55. PubMed ID: 10179343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The ability of current biologics law to accommodate emerging technologies.
    Carter MJ
    Food Drug Law J; 1996; 51(3):375-80. PubMed ID: 11797714
    [No Abstract]   [Full Text] [Related]  

  • 14. Blood vessels recovered with organs and intended for use in organ transplantation. Final rule.
    Food and Drug Administration, Health Resources and Services Administration, HHS
    Fed Regist; 2007 Mar; 72(47):10922-5. PubMed ID: 17450655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The FDA "reinvents" human cell and tissue regulations.
    Brower V
    Nat Biotechnol; 1997 May; 15(5):411. PubMed ID: 9131612
    [No Abstract]   [Full Text] [Related]  

  • 16. Infections associated with musculoskeletal-tissue allografts.
    Polder JA; Wood JJ; Braun MM
    N Engl J Med; 2004 Sep; 351(13):1358-60; author reply 1358-60. PubMed ID: 15390367
    [No Abstract]   [Full Text] [Related]  

  • 17. Reforming the Human Tissue Acts.
    McKelvie H
    J Law Med; 2006 Nov; 14(2):167-8. PubMed ID: 17153521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FDA regulation of human cloning: usurpation or statesmanship?
    Merrill RA; Rose BJ
    Harv J Law Technol; 2001; 15(1):85-148. PubMed ID: 15156886
    [No Abstract]   [Full Text] [Related]  

  • 19. Establishment registration and listing for manufacturers of human cellular and tissue-based products--FDA. Proposed rule; reopening of comment period.
    Fed Regist; 1998 Dec; 63(237):68212-3. PubMed ID: 10338885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Understanding external controls over the commercial introduction of engineered human tissues. Assessing regulatory and liability issues.
    Smith DS
    Clin Plast Surg; 1999 Oct; 26(4):537-48, vii. PubMed ID: 10553211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.